Wednesday, March 27, 2013

DePuy ASR Hip Recall: Bernstein Liebhard LLP Comments on New Study Which Found Revision Rates Continue to Increase, Two Years after DePuy ASR Hip Replacement Recall

York, NY (PRWEB) March 25, 2013
As DePuy ASR lawsuits continue to move through the courts, Bernstein Liebhard LLP notes that a new study has found revision rates associated with the Articular Surface Replacement XL system continue to rise, two years after the DePuy ASR hip replacement recall was announced. The study, which was presented at this year’s Annual Meeting of the American Academy of Orthopaedic Surgeons, looked at repeat surgeries among patients who received the ASR hip at one facility in 2006 and 2009. At 3-years of follow-up, 19% of ASR patients had undergone revision surgery to replace their implant, according to the study abstract. By 4-years, the revision rate had risen to 24%, with almost half of the women who'd received the new hip requiring repeat surgery. The facility where the study was conducted terminated use of the hip 18 months before the DePuy ASR hip recall was announced in August 2010. By that time, 359 ASR hips had been implanted in 314 patients.*

“The study’s findings really aren’t that surprising given the revision rates we are seeing in our own clients. We continue to hear from patients affected by the DePuy ASR hip replacement recall who have allegedly suffered failure of their implant. What this research indicates is that many more ASR hip recipients could still be at risk for premature failure of their device,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is actively filing DePuy ASR lawsuits on behalf of individuals who allegedly suffered metallosis, early device failure and other complications related to the DePuy ASR hip recall.

Read more:

No comments:

Post a Comment